Navigation Links
Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
Date:5/29/2013

EXTON, Penn., May 29, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatoid arthritis patients are moderately to highly satisfied with the drugs, biologic and non-biologic, they are currently taking for their condition. Most of the surveyed patients indicate they are unlikely to request a change in therapy in the next year, supporting the finding that they are satisfied with their current medication.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO)

The PatientTrends® Rheumatoid Arthritis (US) 2013 report finds that conventional disease-modifying antirheumatic drugs (DMARDs) are rated highest on ease of use and cost due to their oral formulations and generic availability. However, despite the fact that Pfizer's Xeljanz is a new oral agent, rheumatoid arthritis patients express a low likelihood to ask their doctor to prescribe Xeljanz, post-exposure to Xeljanz's profile. The high patient drug satisfaction finding is contrary to rheumatologists' views of the currently available rheumatoid arthritis drug treatments where, in the TreatmentTrends® Rheumatoid Arthritis (US) 2012 report, close to 50 percent of surveyed rheumatologists rated rheumatoid arthritis as a disease with a high unmet need for new drug therapies.   

"Approximately half of the surveyed rheumatoid arthritis patients taking conventional DMARDs and/or biologics do not experience any side effects," said BioTrends Senior Data Analyst Jen Dolga . "Therefore, if their current drug is working and they are not experiencing side effects, the patients are not going to ask their doctors to change their medication."

About BioTrends Research Group
BioTrends Research Grou
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
2. Patent Issued In U.S. For EntreMeds 2ME2 In Rheumatoid Diseases
3. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
4. Specialty drug costs account for more than 50 percent of the total cost of care for rheumatoid arthritis and hepatitis C patients
5. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
6. Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
7. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
8. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
9. UCB, Inc. and Arthritis Foundation Partner to Celebrate the "Everyday Victories" of the Rheumatoid Arthritis Community
10. Epidemiology: Rheumatoid Arthritis in China - Rapid urbanization presents favorable market potential
11. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015  Protiviti, a global consulting firm, ... Auditing around the World publication ( www.protiviti.com/iaworld ). ... reported on the evolution of the internal audit profession ... globe as a means to providing senior executives and ... strategic business function. The 2015 edition of ...
(Date:7/6/2015)... -- Hologic, Inc. (NASDAQ: HOLX ) announced today ... for the third quarter of fiscal 2015 on Wednesday, ... with the release, management will host a conference call ... Interested participants may listen to the call by dialing ... or 719-325-4804 (for international callers) and referencing access code ...
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp ... will present live at VirtualInvestorConferences.com on July 9, 2015. ... LINK: http://tinyurl.com/e-qure-presentation This will ... invited to ask the company questions in real-time - ... association,s "virtual trade booth." If attendees are not able ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... ARBOR, Mich., Sept. 17 Terumo Heart, ... European Launch Symposium at the European,Association of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ) (Logo: ... of the European Clinical Trial results for ...
... to enter Phase 2 clinical development, PRINCETON, ... an innovator in the discovery and development of ... a Phase 2a,clinical study of PS433540, the company,s ... and endothelin receptor antagonist,(DARA) that is being developed ...
Cached Medicine Technology:Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 4Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 5
(Date:7/6/2015)... ... July 06, 2015 , ... ... southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health ... other serious medical conditions. Screenings are affordable and accurate and run about an ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... Seedstock ... deliver the keynote address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation ... year’s conference , held at the University of California-San Diego, will explore solutions ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... area, Carlson & Associates has once again teamed up with Family Emergency Shelter ... families to move toward self-sufficiency. FESCO was created especially to provide emergency services ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking ... reduce their risk of having a fracture through the bone health screenings conducted by ... , “We are participating because our residents need this information to remain independent and ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... $400,000 in grant funds to support a three-year effort to reduce rates of ... will be conducted in partnership with the Morehouse School of Medicine’s Prevention Research ...
Breaking Medicine News(10 mins):Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... Moms and Babies, Bad for Mercury Fear,Campaign, WASHINGTON, ... for pregnant women, issued this morning by,the National Healthy ... at the nonprofit Center for Consumer Freedom,made the following ... and mercury swung back in the,direction of common sense. ...
... a departure from,current FDA and EPA guidelines, an ... childbearing age to increase their seafood,consumption, despite the ... other contaminants commonly found in seafood., "It,s ... fish without,mentioning the documented public health risks associated ...
... PRINCETON, N.J., Oct. 4 The following is a,statement ... their health information online:, It is encouraging that ... develop personal health record (PHR) products and systems,that people ... we,hope more companies will follow suit. Having ready access ...
... fired for managing diabetes at work but whose ... before House Judiciary,Subcommittee about his experience, ALEXANDRIA, ... reiterated its strong support for the ADA,Restoration Act, ... landmark,1990 Americans with Disabilities Act. On Thursday, the ...
... Psychemedics Corporation,(AMEX: PMD ) today announced that ... Controller. Jennifer will be responsible for all ... the financial analysis and planning,activities necessary for the ... Chairman and CEO. Since 1999, Jennifer has ...
... My Diabetes Connector, provides patients with virtual diabetes health- ... ... The American,Diabetes Association today unveiled a new web-based diabetes tool ... care providers -- to,share and organize important health information to ...
Cached Medicine News:Health News:Consumer Group Statement on Seafood and Health: 'We Told You So' 2Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 3Health News:Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
For connection to the bipolar output of electrosurgical generators....
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... for orthopedic procedures. Molded armrests ... 24" for the surgeon's comfort. ... to any O.R. table. Split ... and stability. Optional post or ...
Medicine Products: